Literature DB >> 16200871

[Combined effects of endostatin gene transfer and ionizing radiation on lung adenocarcinoma model of A549-cells].

Chun-hua Ling1, Cheng Ji, Yan-bin Chen, Jian-xin Fu, Ju-ying Zhou, Wei-chang Chen, Ji-cheng Yang, Liao-yuan Su.   

Abstract

OBJECTIVE: The combined inhibition effects of endostatin gene transfer and ionizing radiation on lung adenocarcinoma model of A549-cell were investigated.
METHODS: Human endostatin gene was transferred into lung adenocarcinoma A549 cell by retrovirus-mediation to obtain an A549/Endo cell. A549 and A549/Endo cells were xenoimplanted in nude mice respectively (each group included 10 mice). Then, the changes of the tumor size of each group (n = 5) and its growth inhibition rate were estimated. The implanted tumors of each group (n = 5) were exposed to radiation with 20 Gy at 28 day after implantation. They were irradiated again with 20 Gy 3 day later. The ionizing radiation was strictly confined to the tumor by shielding the rest of the body with lead. The size of tumor was measured periodically. The microvessel density (MVD) of 4 groups of implanted tumors (A549, A549/Endo, A549 + IR and A549/Endo + IR) were compared on day 42 postgrafting by the immunohistochemical method.
RESULTS: PCR confirmed that endostatin gene was inserted into the genomic DNA of human lung adenocarcinoma A549 cell. The tumor formation time showed significant difference (P < 0.05) between group A549 (7.8 +/- 1.6) d and group A549/Endo (12.2 +/- 1.7) d. At the time of day 42 postgrafting, the tumor sizes of group A549 and group A549/Endo were (927.8 +/- 269.2) mm3 and (217.5 +/- 81.5) mm3 respectively (P < 0.01), and the tumor growth inhibition rate was 76. 5%. At the time of day 14 after irradiation, the tumor sizes of group A549 and group A549/Endo were (157.7 +/- 49.0) mm3 and (4.6 +/- 2.9) mm3 respectively (P < 0.01). The results of immunohistochemical detection showed that the MVD of-A549/Endo implanted tumor was significantly decreased [21.62 +/- 3.55 compared with A549 implanted tumor 35.78 +/- 5.67 (P < 0.01)]. Moreover , it also showed that ionizing radiation could further reduce the MVD of A549/Endo implanted tumor from 21.62 +/- 3.55 to 11.32 +/- 2.78 (P < 0.01).
CONCLUSIONS: Retroviruses can highly mediate the transfer of endostatin gene into the adenocarcinoma cells. Endostatin gene transfer can inhibit the xenoimplanted tumor growth by its direct inhibition on neovascularization. The combination of endostatin gene transfer with ionizing radiation treatment can synergistically inhibit the neovascularization and the growth of lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16200871

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  4 in total

1.  Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC.

Authors:  Xiao-Dong Jiang; Yun Qiao; Peng Dai; Jin Wu; Da-An Song; Shi-Qiu Li; Yue-Wei Fan
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

2.  Clinical study on the recombinant human endostatin regarding improving the blood perfusion and hypoxia of non-small-cell lung cancer.

Authors:  Xiao-Dong Jiang; Peng Dai; Yun Qiao; Jin Wu; Da-An Song; Shi-Qiu Li
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

3.  Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis.

Authors:  Xiao-Dong Jiang; Yun Qiao
Journal:  Transl Lung Cancer Res       Date:  2012-03

4.  Enhancement of recombinant human endostatin on the radiosensitivity of human pulmonary adenocarcinoma A549 cells and its mechanism.

Authors:  Xiao-dong Jiang; Yun Qiao; Peng Dai; Qin Chen; Jin Wu; Da-an Song; Shi-qiu Li
Journal:  J Biomed Biotechnol       Date:  2012-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.